Complementary therapies in clinical practiceHumansMetabolic SyndromeDrugsChinese HerbalGlycolipids
Comparative efficacy and safety of Chinese patent medicines as adjunctive therapies for glycolipid regulation in metabolic syndrome: A network meta-analysis.
Zhilin Chen, Haoyue Shi, Juju Shang, Wenchu Kang, Yuhan Hao, Xuerui Zhao, Sinai Li, Yifeng Shen
Published: 202510.1016/j.ctcp.2025.102024
Abstract
BACKGROUND AND PURPOSE: Effective management of glycolipid metabolism is key to reducing the risk of cardiovascular disease in patients with metabolic syndrome (MetS). Chinese patent medicines (CPMs), a type of standardized herbal formulation, are wi…
Preview only. Read the full abstract at the source